DE69513027D1 - Verfahren zur bestimmung des präthrombotischen status - Google Patents

Verfahren zur bestimmung des präthrombotischen status

Info

Publication number
DE69513027D1
DE69513027D1 DE69513027T DE69513027T DE69513027D1 DE 69513027 D1 DE69513027 D1 DE 69513027D1 DE 69513027 T DE69513027 T DE 69513027T DE 69513027 T DE69513027 T DE 69513027T DE 69513027 D1 DE69513027 D1 DE 69513027D1
Authority
DE
Germany
Prior art keywords
determining
prehrombotic
status
amount
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69513027T
Other languages
English (en)
Other versions
DE69513027T2 (de
Inventor
Jean-Marie Freyssinet
Benedicte Antoni
Frederic Donie
Helmut Lill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Freyssinet SAS
Original Assignee
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics GmbH filed Critical Roche Diagnostics GmbH
Application granted granted Critical
Publication of DE69513027D1 publication Critical patent/DE69513027D1/de
Publication of DE69513027T2 publication Critical patent/DE69513027T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4718—Lipocortins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69513027T 1994-07-23 1995-07-19 Verfahren zur bestimmung des präthrombotischen status Expired - Lifetime DE69513027T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94111514 1994-07-23
PCT/EP1995/002846 WO1996003655A1 (en) 1994-07-23 1995-07-19 Method for the determination of the prethrombotic state

Publications (2)

Publication Number Publication Date
DE69513027D1 true DE69513027D1 (de) 1999-12-02
DE69513027T2 DE69513027T2 (de) 2000-03-16

Family

ID=8216140

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69513027T Expired - Lifetime DE69513027T2 (de) 1994-07-23 1995-07-19 Verfahren zur bestimmung des präthrombotischen status

Country Status (7)

Country Link
US (1) US7005271B1 (de)
EP (1) EP0772778B1 (de)
JP (1) JP3574659B2 (de)
AT (1) ATE186121T1 (de)
DE (1) DE69513027T2 (de)
ES (1) ES2139957T3 (de)
WO (1) WO1996003655A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999002992A1 (en) * 1997-07-11 1999-01-21 The Mount Sinai School Of Medicine Of The City University Of New York Assays for diagnosis of thrombophilic disease
US7687272B1 (en) 1998-01-12 2010-03-30 Henry Buchwald Method and apparatus for determining blood oxygen transport
WO2000025140A1 (en) * 1998-10-23 2000-05-04 Accumetrics, Inc. Method for determining platelet count
US6806091B1 (en) 1999-01-12 2004-10-19 Henry Buchwald Method and apparatus for determining blood oxygen transport
CA2385371A1 (en) * 2000-07-21 2002-01-31 Hiroshi Mizokami Method of purifying calcium ion-binding protein
ATE359807T1 (de) 2001-02-21 2007-05-15 Surromed Inc Modifizierte annexin-proteine und verhinderung und behandlung von thrombose
US7635676B2 (en) 2001-02-21 2009-12-22 Alavita Pharmaccuticals, Inc. Modified annexin proteins and methods for their use in organ transplantation
US7635680B2 (en) 2001-02-21 2009-12-22 Alavita Pharmaceuticals, Inc. Attenuation of reperfusion injury
US7645739B2 (en) 2001-02-21 2010-01-12 Alavita Pharmaceuticals, Inc. Modified annexin compositions and methods of using same
US6746872B2 (en) 2002-01-16 2004-06-08 Lifescan, Inc. Control compositions and methods of use for coagulation tests
US20070243632A1 (en) 2003-07-08 2007-10-18 Coller Barry S Methods for measuring platelet reactivity of patients that have received drug eluting stents
ES2378544T3 (es) 2003-07-08 2012-04-13 Accumetrics, Inc. Activación selectiva de plaquetas para el seguimiento de terapia con antagonistas de ADP
DE602007010246D1 (de) * 2006-01-27 2010-12-16 Rappaport Family Inst For Res Verfahren zur blutgerinnungsbestimmung
FR2917172B1 (fr) * 2007-06-07 2014-01-03 Inst Nat Sante Rech Med Methode de mesure de l'activite plasmine des microparticules presentes dans un echantillon de fluide biologique et utilisation
US20100255514A1 (en) * 2007-08-16 2010-10-07 The Royal Institution For The Advancement Of Learning/Mcgill University Tumor cell-derived microvesicles
EP2176665B1 (de) 2007-08-16 2016-03-02 The Royal Institution for the Advancement of Learning / McGill University Tumorzellen-abgeleitete mikrovesikel
EP2598652A4 (de) 2010-07-29 2014-04-30 Shire Human Genetic Therapies Tests zum nachweis von glykosaminoglykanen
EP2809796A4 (de) * 2012-02-01 2016-08-17 Shire Human Genetic Therapies Tests zum nachweis von glykosaminoglykanen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668638A (en) 1983-03-24 1987-05-26 The Liposome Company, Inc. Liposome composition for lupus assay
FR2621128B1 (fr) 1987-09-30 1994-05-06 Sanofi Trousse et methode de dosage immunometrique applicables a des cellules entieres
US5340719A (en) 1990-11-23 1994-08-23 Corporation Coulter Method and apparatus for optically screening microscopic cells
US5266462A (en) * 1992-06-03 1993-11-30 Baxter Diagnostics Inc. Measurement of platelet activities
CA2072548A1 (en) 1992-06-26 1993-12-27 Michael W. Stewart Methods for determining antiphospholipid antibodies
DE4229933A1 (de) * 1992-09-08 1994-03-10 Max Planck Gesellschaft Verfahren zur Bestimmung von Thrombose verursachenden Lupus-anticoagulant-Antikörpern
US5472852A (en) * 1993-09-15 1995-12-05 Oklahoma Medical Research Foundation Assay for detection of selective Protein C inhibition by patients

Also Published As

Publication number Publication date
JP3574659B2 (ja) 2004-10-06
ATE186121T1 (de) 1999-11-15
DE69513027T2 (de) 2000-03-16
EP0772778A1 (de) 1997-05-14
US7005271B1 (en) 2006-02-28
WO1996003655A1 (en) 1996-02-08
EP0772778B1 (de) 1999-10-27
JPH10503023A (ja) 1998-03-17
ES2139957T3 (es) 2000-02-16

Similar Documents

Publication Publication Date Title
ATE186121T1 (de) Verfahren zur bestimmung des präthrombotischen status
TR199801390T2 (xx) Tromboz tedavisinde kullan�lacak p�ht�la�may� �nleyici maddeler
DE69010893D1 (de) Verfahren zur behandlung von koks sowie löschen desselben.
FI843496A (fi) Anordning foer att finna tvaergaoende borrhaol i implantat i benmaergen.
DE69535448D1 (de) Vorrichtung zur Unterdrückung von stimulierter Brillouin Streuung
DE69711034D1 (de) Wässrige fluorpolymerlösungen zur behandlung von harten oberflächen
DE3486081T2 (de) Verfahren und testzusammensetzung zur bestimmung von wasserstoffperoxid.
DE69630955D1 (de) Immortalisierung bzw. desimmortalisierung von zellen
ATE127853T1 (de) Verfahren zur bestimmung der funktionellen wirkung von freiem protein s oder protein c in einer plasmaprobe.
DE59804931D1 (de) Verfahren zur selektiven hydrierung von ethylenisch ungesättigten doppelbindungen in polymerisaten
DE69525226T2 (de) Vorrichtung und Verfahren zur Bestimmung von Wasserstoffperoxid
DE3585238D1 (de) Verfahren zur bestimmung des reduzierten zustands von nicotinamid-adenin-dinukleotid.
TR199801988T2 (xx) Kalp yetmezli�inin endotelin antagonistleri ile tedavisi i�in y�ntem.
DE3785380T2 (de) Analytische Zusammensetzung, Element und Verfahren zur Bestimmung von Wasserstoffperoxid.
DE3678621D1 (de) Verfahren und testzusammensetzung zur bestimmung von wasserstoffperoxyd.
DE59105482D1 (de) Verfahren und Mittel zur kolorimetrischen Bestimmung von Nitrationen.
DE3586371D1 (de) Verfahren zur behandlung des bodens und zusammensetzung zur konservierung von stickstoff im boden.
IT8420757A0 (it) Metodi e composizioni di fumigazione.
IT8447751A0 (it) Composizione contenente polisaccaride per legare proteine specifiche, metodo per ottenerla e procedimento nonche' corredo di saggio che la impiegano
DE69023710D1 (de) Verfahren zur bestimmung von enzymatischer wirksamkeit.
DE69013888D1 (de) Verfahren zur chromatographischen Bestimmung von Ionen.
DE3790942T1 (de) Verfahren zur quantitativen bestimmung des fremdstoffgehaltes in einer legierung
DE3680172D1 (de) Verfahren zur behandlung von protistezellen.
DE3585919D1 (de) Verfahren zur behandlung von zellen.
DE68906651D1 (de) Zusammensetzung und verfahren zur behandlung von metalloberflaechen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: FREYSSINET, JEAN MARIE, DR., STRASSBURG/STRASBOURG

8328 Change in the person/name/address of the agent

Free format text: WEICKMANN & WEICKMANN, 81679 MUENCHEN